MMV is proud to have co-developed medicines that have contributed to easing the malaria burden and echoes WHO call for increased commitment to end malaria for good in the face of new challenges.
treatments of child-friendly Coartem® Dispersible distributed to more than 50 countries since 2009, saving around 860 000 lives
of injectable artesunate for severe malaria delivered since 2010, saving the lives of over 1m additional vulnerable children compared with quinine treatment
shipped free of charge to scientists around the world to boost drug discovery for neglected diseases
Discover how enhancing African manufacturing capacity can increase IPTp coverage in this Q&A in French and English.
Take a look at her statement urging all African leaders to fully commit to the protection of young girls from malaria.
Read more about MMV's initiative to combat malaria in women who are of reproductive potential, pregnant or breastfeeding.